Bradley T Messmer

Title: The Innovations of Bradley T Messmer

Introduction

Bradley T Messmer is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biomedical research, particularly in the detection and quantification of therapeutic monoclonal antibodies. With a total of 7 patents, his work has advanced the methodologies used in clinical diagnostics.

Latest Patents

Messmer's latest patents include innovative methods and assays for detecting natalizumab in various samples. These patents describe point-of-care devices that facilitate the detection of natalizumab-peptide complexes. Additionally, he has developed methods for detecting antibodies that involve complexes comprising a therapeutic monoclonal antibody and a peptide. These peptides can range from 5 to 40 amino acids in length and may include mimetopes recognized by the therapeutic monoclonal antibody.

Career Highlights

Throughout his career, Messmer has worked with esteemed institutions such as the University of California and Abreos Biosciences, Inc. His research has focused on enhancing the accuracy and efficiency of antibody detection, which is crucial for patient care and treatment monitoring.

Collaborations

Some of his notable coworkers include Thomas James Kipps and Ana B Sanchez. Their collaborative efforts have contributed to the advancement of research in the field of monoclonal antibodies.

Conclusion

Bradley T Messmer's innovative work in the detection of therapeutic monoclonal antibodies has made a significant impact in biomedical research. His contributions continue to influence the development of diagnostic methods that improve patient outcomes.